Elite Health Systems (EHSI) CEO adds 42,105 shares in open-market buy

Rhea-AI Filing Summary

Elite Health Systems Inc. CEO and director Jeereddi Prasad Anjaneya reported an open-market purchase of common stock. On this Form 4, he bought 42,105 shares of Elite Health Systems common stock at $0.95 per share, classified as a direct holding. After this transaction, he directly owns 3,624,484 common shares. A separate entry reports 225,716 common shares held indirectly through an entity for which he is a managing member and major equity owner, giving investors a view of both his direct and indirect equity exposure.

Insider Trade Summary

Net Buyer: 42,105 shares ($40,000)

Net Buy 2 txns

Insider jeereddi Prasad Anjaneya

Role CEO

Bought 42,105 shs ($40K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	42,105	$0.95	$40K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 3,624,484 shares (Direct); Common Stock — 225,716 shares (Indirect, See footnote)

Footnotes (1)

1. [object Object]

Key Figures

Shares purchased: 42,105 shares Purchase price: $0.95 per share Direct holdings after transaction: 3,624,484 shares +1 more

4 metrics

Shares purchased 42,105 shares Open-market common stock purchase on 2026-07-02

Purchase price $0.95 per share Price for common stock bought on 2026-07-02

Direct holdings after transaction 3,624,484 shares Common stock directly owned following purchase

Indirect holdings reported 225,716 shares Common stock held by related entity with CEO as managing member

Key Terms

open-market purchase, indirect ownership, managing member

3 terms

open-market purchase financial

"transaction_action: open-market purchase"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

indirect ownership financial

"ownership_type: indirect; nature_of_ownership: See footnote"

managing member financial

"entity of which the Reporting Person is a managing member and major equity owner"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/09/2026 - 03:02 PM Accepted by SEC EDGAR 07/09/2026 - 03:02 PM Learn about SEC filing dates

FAQ

What insider transaction did EHSI CEO report on this Form 4?

The CEO reported an open-market purchase of Elite Health Systems common stock. He bought 42,105 shares at $0.95 per share, increasing his directly held stake in the company’s equity.

How many Elite Health Systems (EHSI) shares does the CEO hold after this filing?

After the reported purchase, the CEO directly holds 3,624,484 common shares. The Form 4 also shows an additional 225,716 common shares held indirectly through an entity he manages and significantly owns.

Was the EHSI CEO’s Form 4 transaction a buy or a sell?

The Form 4 shows a buy transaction by the CEO. It records an open-market purchase of 42,105 Elite Health Systems common shares at a price of $0.95 per share, with no reported sales.

What price did the EHSI CEO pay per share in the reported transaction?

The CEO paid $0.95 per share for Elite Health Systems common stock. The filing classifies this as an open-market or private purchase of 42,105 shares, increasing his direct ownership position.

How many Elite Health Systems (EHSI) shares are held indirectly for the CEO?

The Form 4 lists 225,716 common shares held indirectly. These shares are owned by an entity where the reporting person is a managing member and major equity owner, reflecting additional indirect exposure to EHSI.

Does the EHSI Form 4 involve any derivative securities or options?

The filing shows only common stock positions and transactions. The derivative summary is empty, indicating no reported option exercises, warrants, or other derivative security transactions in this particular Form 4.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

jeereddi Prasad Anjaneya

(Last) (First) (Middle)

1131 W. 6TH STREET

SUITE 225

(Street)

ONTARIO CALIFORNIA 91762

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Elite Health Systems Inc. [ EHSI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/02/2026	07/02/2026	P		42,105	A	$0.95	3,624,484	D
Common Stock								225,716	I	See footnote(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares held by an entity of which the Reporting Person is a managing member and major equity owner.

	/s/ Prasad A Jeereddi	07/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)